retatrutide vs semaglutide vs tirzepatide Retatrutide: 2026 Chicago Guide The GLP-1s-Semaglutide, Tirzepatide & Retatrutide:

51 The Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity (SURMOUNT-OSA) trial reported that tirzepatide (10 mg or 15 mg) significantly reduced the apnoeahypopnea index in people with moderate to severe obstructive sleep apnoea and obesity

doi: 10.1677/joe.0.1650093 100 EllingsgaardHEhsesJAHammarEBLommel VanLQuintensRMartensGet al

Others continue with the compound formulation for the ongoing nutritional support

Position of the Academy of Nutrition and Dietetics: medical nutrition therapy behavioral interventions provided by dietitians for adults with overweight or obesity, 2024

Open communication and adjusting dosing schedules can help ease mild concerns